Cargando…
What Is the Best Drug to Treat COVID-19? The Need for Randomized Controlled Trials
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the biggest public health challenge to the biomedical community of the last century. Despite multiple public health measures,1, 2, 3 there remains an urgent need for pharmacologic therapies to treat infected patients, mini...
Autores principales: | Ottaviani, Silvia, Stebbing, Justin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235589/ https://www.ncbi.nlm.nih.gov/pubmed/32838354 http://dx.doi.org/10.1016/j.medj.2020.04.002 |
Ejemplares similares
-
The need to improve the laws and regulations relevant to the outbreak of COVID-19: What might be learned from China?
por: Li, Hao, et al.
Publicado: (2020) -
The Need for Education and Clinical Best Practice Guidelines in the Era of Direct-to-Consumer Genomic Testing
por: Myers, Madeleine, et al.
Publicado: (2020) -
The need to implement non-industry COVID-19 clinical trials in non-high-income countries
por: Dal-Ré, Rafael, et al.
Publicado: (2020) -
Learning from tuberculosis: COVID-19 highlights the need for more robust infection control policy
por: Moran, Alexander, et al.
Publicado: (2020) -
Scaled testing for COVID-19 needs community involvement
por: Adams, Emily R, et al.
Publicado: (2021)